Alvotech SA
ALVO4.12015.41% ( +0.550 )
Alvotech SA (ALVO)
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic area...
- Open
- 3.580
- High
- 4.120
- Low
- 3.540
- Prev. Close
- 3.570
- Volume
- 1.72M
- Turnover
- 6.69M
- Avg Price
- 3.888
- Bid/Ask Ratio
- --
- Amplitude
- 16.25%
- 52wk High
- 9.455
- Volume Ratio
- 2.11
- Turnover Ratio
- 1.52%
Alvotech SA Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$5.7539.56%
Forecast & RatingBuy
5analysts
- Strong buy40.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell20.00%
News
- Market Beat · Jul 30 at 03:44 AM
Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages
- PUBT · Jul 29 at 08:26 AM
Alvotech says FDA closes Reykjavik plant inspection with VAI classification
- StockTitan · Jul 29 at 12:25 AM
Alvotech announces successful closure of FDA inspection of manufacturing facility | ALVO Stock News
- Market Beat · Jul 23 at 12:00 PM
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading Volume - Should You Buy?
- Market Beat · Jul 22 at 01:20 PM
Alvotech (NASDAQ:ALVO) Stock Price Down 7.8% - Here's What Happened
- Simplywall · Jul 5 at 03:11 AM
Alvotech (ALVO) Secured $240 Million In New Capital, Is The Stock Cheap?
